VitaHold facilitates maximum reproducible breath-holding.
DIBH treatments help to minimise radiation doses to organs at risk, while
reducing complications later in life. During treatment, the patient's heart is
moved away from the chest wall and the targeted tumour, allowing breathing.
Your automated surface-guided radiation monitoring position continuously
monitors breathing and positions in the cameras for radiation delivery. This
method allows care teams to effectively position the patient and confidently
monitor their accuracy. "Our goal in offering VitalHold for the Radixact
System is to give clinicians additional choice and flexibility when treating
all the breast cancer cases they see every day in their practice," said
Suzanne Winter, President and CEO of Accuray. "Now Accuray can offer our
customers the widest range of radiation therapy delivery techniques in a single
device, the Radixact System. This industry-leading approach demonstrates how
our relentless focus on innovation is making Accuray's already great system
even better, providing clinicians with tools that help ensure precise, truly
personalised treatments are available to more patients."
Radixact ensures precise delivery of radiation to any tumour
bed during each treatment, while minimising doses to nearby healthy organs and
tissues. It allows radiation therapy as a treatment option for breast cancer at
almost any stage. Areas of use include post-operative, chemotherapy and other
drugs.
Redixact, a CT Linac-Based system, provides multiple radiation delivery options to tailor treatment to the patient's needs, enabling clinicians to treat breast cases in as little as two minutes. The system's TomoHelical mode continuously delivers radiation beams around the patient. This feature realises the treatment of complex cases such as breast cancer and cancer in the surrounding lymph nodes.
"You can be sure
that it will touch the lives of countless breast cancer patients"
Cecilia de Leeuw, CEO and president of C-RAD, said,
"C-RAD is incredibly proud of our collaboration with Accuray. Together, we
have created a seamless integration between our systems to ensure the highest
level of accuracy and efficiency for breast cancer treatment." "VitalHold
is a powerful application of C-RAD's proven SGRT technology and is sure to
touch the lives of countless breast cancer patients."